Arrowhead Pharmaceuticals
ARWR
#2223
Rank
HK$67.58 B
Marketcap
HK$479.82
Share price
-0.65%
Change (1 day)
64.40%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2026 (TTM): -HK$26.13

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$26.13. In 2025 the company made an earnings per share (EPS) of -HK$0.07848 an increase over its 2024 EPS that were of -HK$39.24.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$26.1333201.36%
2025-HK$0.07848-99.8%
2024-HK$39.24161.39%
2023-HK$15.0117.36%
2022-HK$12.7919.85%
2021-HK$10.6761.9%
2020-HK$6.59-216.67%
2019HK$5.65-210.77%
2018-HK$5.1038.3%
2017-HK$3.69-64.93%
2016-HK$10.52-16.25%
2015-HK$12.5628%
2014-HK$9.81-3.85%
2013-HK$10.20-31.58%
2012-HK$14.91331.82%
2011-HK$3.45-51.11%
2010-HK$7.06-79.07%
2009-HK$33.75-37.68%
2008-HK$54.15-16.87%
2007-HK$65.1438.33%
2006-HK$47.09122.22%
2005-HK$21.1942.11%
2004-HK$14.91533.33%
2003-HK$2.35-99.08%
2002-HK$254.8025%
2001-HK$203.8433.33%
2000-HK$152.88-120%
1999HK$764.41-400%
1998-HK$254.80-81.48%
1997-HK$1,376

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.54-362.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-HK$62.70 139.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$78.56-400.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$43.40-266.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-HK$14.36-45.05%๐Ÿ‡บ๐Ÿ‡ธ USA